The Company builds value in revenue-stage information technology and life sciences businesses. It provides growth capital as well as a range of strategic, operational and management resources to its partner companies.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
With the gain and cash from the Mantas sale, the company will have substantial resources to continue investing in new companies. While venture capital is always risky, the company has some interesting potential given its company roster and enhanced resources. You do have to hold your nose at management's absurdly high options compensation.
Agree. This stock is in the 2nd tier of my stock selection criteria. See blog post re: selection criteria.